- Is chronic plaque psoriasis triggered by microbiota in the skin?2013 | Faculty of Medicine in Pilsen
- Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study2020 | Faculty of Medicine in Pilsen
- Efalizumab therapy of plague psoriasis +12008 | Faculty of Medicine in Hradec Králové
- Efalizumab therapy of plague psoriasis2008 | First Faculty of Medicine
- Inhibition of interleukins 12 and 23 - experience of plaque psoriasis therapy by ustekinumab2013 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CAIN457A2304E1Publication without faculty affiliation
- Individualized pharmacotherapy of plaque psoriasis with oral methotrexate: fiction or real possibility?2012 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Certolizumab pegol in the treatment of focal psoriasis2020 | Second Faculty of Medicine
- Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal2019 | Faculty of Medicine in Pilsen
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CAIN457A2304Publication without faculty affiliation
- Biologic treatment of chronic severe psoriasis2012 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Biologic treatment of chronic severe psoriasis2012 | Publication without faculty affiliation
- New knowledce about etanercept biological therapy of plaque psoriasis2009 | Faculty of Medicine in Hradec Králové
- New knowledce about etanercept biological therapy of plaque psoriasis2009 | First Faculty of Medicine
- Czech Recommendations for Biological Therapy of Severe Plaque Psoriasis2012 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Czech Recommendations for Biological Therapy of Severe Plaque Psoriasis2012 | Publication without faculty affiliation
- Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial2020 | Faculty of Medicine in Pilsen
- Advances in biological therapy for psoriasis2017 | First Faculty of Medicine
- Cílená UV-B fototerapie ložiskové psoriázy (P. Asawanonda - A. Chingchai - P. Torranin: Targeted UV-B Phototherpy for Plaque-type Psoriasis. In: Arch Dermatol. 2005;141:1542-1546)2006 | First Faculty of Medicine
- Patient with psoriasis and metabolic syndrome. Thanks to the topical application of Enstilar foam we avoided to immediately need of systemic treatment in psoriasis2019 | Faculty of Medicine in Hradec Králové
- Znáhodněná dvojitě slepá studie léčby chronické ložiskové psoriázy (Yones, SS., Palmer, RA., Garibaldinos, TG., Hawk JLM.: Randomized Double-blind Trial of the Treatment of Chronic Plaque Psoriasis)2007 | First Faculty of Medicine
- Excimer laser in psoriasis therapy : commentary2008 | Faculty of Medicine in Hradec Králové
- Commentary to the study2019 | Faculty of Medicine in Hradec Králové
- Research Report University Hospital for clinical assessment CAIN457A2304E1Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: A3921061Publication without faculty affiliation
- Ideal patient for IL-17 inhibitors treatment2022 | First Faculty of Medicine
- X-ray therapy of benign skin diseases2010 | First Faculty of Medicine
- Our Experience with Ustekinumab for the Treatment of Psoriasis2011 | Second Faculty of Medicine
- Bimodal immune activation in psoriasis2014 | Faculty of Medicine in Pilsen